Global Hepatitis C Virus (HCV) Market Report: 2016 Edition - Major Players are Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Hepatitis C Virus (HCV) Market Report: 2016 Edition" report to their offering.

Hepatitis C Virus (HCV) is an infection which affects the liver which may lead to serious consequences if not taken care of. It spreads through infected blood transfusions and poorly sterilized medical equipments. The number of patients has increased significantly because its symptoms take time to be recognized before the patient progresses towards a clinically visible liver damage which worsens the situation since it may lead to liver damage or even failure. There was no proper therapy for HCV before 2010 but the coming of therapies like Sovaldi and Harvoni by Gilead and Viekira Pak by AbbVie has improved the scenario. Also the steps taken like proper blood screening is also helping in identifying the patients.

The key factors which are anticipated to drive HCV market include medical reimbursement because of the therapy being very costly, growth in the number of patients, relatively smaller period of drug treatment from before, treatment of the warehoused patients who were waiting for a better therapy and pricing discounts and better regimens because of the increased competition. Some of the significant developments of this industry include launch of the interferon free regimen and development of products like Sovaldi, Harvoni and Viekira Pak and the newly identified and diagnosed patients. However, the challenges to be faced ahead is more number of patients asking for reimbursement, increasing competition leading to price cutting, risk associated with drug development and regulatory risk.

This report offers a comprehensive analysis of the HCV market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global HCV market is reined by few major players namely Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.

Key Topics Covered:

1. HCV Market

1.1 An Introduction

1.2 Types of Hepatitis C Virus

1.3 Ways of Spreading of HCV Infection

1.4 HCV Co Infections

1.5 Avoidance of HCV Infection

2. Global HCV Market

2.1 Global HCV Sales by Value

2.2 Global HCV Prevalence by Region

3. Global HCV Market by Region

3.1 The US Market

3.1.1 The US HCV Sales by Value

3.1.2 The US HCV Market Dynamics

3.1.3 HCV Patients Initiated Treatment with Sofosbuvir

3.2 European Union HCV Sales by Value

3.3 Japan HCV Sales by Value

3.4 ROW HCV Sales by Value

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Impact of Reimbursement

4.1.2 Growth in Number of Patients

4.1.3 Smaller Period of Drug Treatment

4.1.4 Improved Economic Growth

4.1.5 Increasing Healthcare Expenditure

4.1.6 Treatment of Warehoused Patients

4.1.7 Global Ageing Population

4.1.8 Pricing Discounts and Better Regimen

4.2 Trends and Development

4.2.1 Launch of Interferon Free Regimen and Development of New Products

4.2.1 Newly Identified and Diagnosed Patients

4.3 Challenges

4.3.1 Increase in Number of Patients for Reimbursement

4.3.2 Increased Competition leading to Price Cut

4.3.3 Risk Associated with Drug Development and Patent

4.3.4 Regulatory Risk

5. Competitive Landscape

5.1 Global Market

5.2 Global Product Sales

5.3 Viekira Vs. Harvoni - Current US Market Scenario

5.4 Viekira Vs. Harvoni - Future US Market Scenario

6. Company Profiles

6.1 Gilead Sciences

6.2 AbbVie

6.3 Johnson & Johnson

6.4 Bristol-Myers Squibb

7. Market Outlook

For more information visit http://www.researchandmarkets.com/research/cbc9ml/global_hepatitis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716